References
- Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 2007; 226: 157–67
- Dickey DT, Wu YJ, Muldoon LL, Neuwelt EA. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther 2005; 314: 1052–8
- Inoue M, Shimizu C, Shimizu H, Tanizawa O. Neutralizing effect of sodium thiosulfate on antitumor efficacy of cisplatin for human carcinoma xenografts in nude mice. Gynecol Oncol 1991; 40: 34–7
- Videhult P, Laurell G, Wallin I, Ehrsson H. Kinetics of cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration. Exp Biol Med (Maywood) 2006; 231: 1638–45
- Yachnin JR, Wallin I, Lewensohn R, Sirzén F, Ehrsson H. The kinetics and cytotoxicity of cisplatin and its monohydrated complex. Cancer Lett 1998; 132: 175–80
- Togawa T, Ogawa M, Nawata M, Ogasawara Y, Kawanabe K, Tanabe S. High performance liquid chromatographic determination of bound sulfide and sulfite and thiosulfate at their low levels in human serum by pre-column fluorescence derivatization with monobromobimane. Chem Pharm Bull (Tokyo) 1992; 40: 3000–4
- Otto WC, Brown RD, Gage-White L, Kupetz S, Anniko M, Penny JE, et al. Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs. Hear Res 1988; 35: 79–85
- Ekborn A, Laurell G, Johnstrom P, Wallin I, Eksborg S, Ehrsson H. D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hear Res 2002; 165: 53–61
- Harned TM, Kalous O, Neuwelt A, Loera J, Ji L, Iovine P, et al. Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity. Clin Cancer Res 2008; 14: 533–40
- Wang J, Lloyd Faulconbridge RV, Fetoni A, Guitton MJ, Pujol R, et al. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology 2003; 45: 380–93
- Baskin SI, Horowitz AM, Nealley EW. The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning. J Clin Pharmacol 1992; 32: 368–75
- Hara A, Salt AN, Thalmann R. Perilymph composition in scala tympani of the cochlea: influence of cerebrospinal fluid. Hear Res 1989; 42: 265–71
- Ding D, McFadden SL, Browne RW, Salvi RJ. Late dosing with ethacrynic acid can reduce gentamicin concentration in perilymph and protect cochlear hair cells. Hear Res 2003; 185: 90–6
- Hahn H, Kammerer B, DiMauro A, Salt AN, Plontke SK. Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration. Hear Res 2006; 212: 236–44
- Laurell G, Andersson A, Engstrom B, Ehrsson H. Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig. Cancer Chemother Pharmacol 1995; 36: 83–6
- Salt AN, Hale SA, Plonkte SK. Perilymph sampling from the cochlear apex: a reliable method to obtain higher purity perilymph samples from scala tympani. J Neurosci Methods 2006; 153: 121–9
- Salt AN, Kellner C, Hale S. Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid. Hear Res 2003; 182: 24–33
- Tobita T, Senarita M, Hara A, Kusakari J. Determination of prednisolone in the cochlear tissue. Hear Res 2002; 165: 30–4
- Chung M, Parravicini L, Assael BM, Cavanna G, Radwanski E, Symchowicz S. Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs. Antimicrob Agents Chemother 1982; 22: 1017–21
- Rybak LP, Green TP, Juhn SK, Morizono T. Probenecid reduces cochlear effects and perilymph penetration of furosemide in chinchilla. J Pharmacol Exp Ther 1984; 230: 706–9